From: CGHpower: exploring sample size calculations for chromosomal copy number experiments
Data Set | Array Type | Probes | Regions | Cancer Type | Groups (Samples) |
---|---|---|---|---|---|
Chin et al. | spotted oligo | 26,755 | 223 | breast | ER+ (113) vs. ER- (57) |
Douglas et al. | BAC | 3,032 | 142 | colorectal | MSI (7) vs. CIN (30) |
Fridlyand et al. | BAC | 1,877 | 231 | breast | TP53+ (10) vs. TP53- (52) |
Myllykangas et al. | cDNA | 11,342 | 260 | gastric | diffuse (15) vs. intestinal (23) |
Nymark et al. | cDNA | 10,953 | 242 | lung | asbestos-exposed (11) vs. non-exposed (9) |
Postma et al. | spotted oligo | 26,755 | 111 | colorectal | good (16) vs. bad response (16) |
Smeets et al. | BAC | 4,196 | 143 | head and neck | HPV+ (12) vs. HPV- (12) |
Wrage et al. | spotted oligo | 25,549 | 23 | lung | BM+ (13) vs. BM- (15) |
Simulation 0 | in-situ oligo | 42,331 | 440 | Â | (15) vs. (15) |
Simulation 5 | in-situ oligo | 42,331 | 489 | Â | (15) vs. (15) |
Simulation 10 | in-situ oligo | 42,331 | 525 | Â | (15) vs. (15) |